Heron Therapeutics | HRTX - Actif À Court Terme





Actif À Court Terme Changement Date
ALKERMES USD 1.52B 164.26M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amarin USD 602.76M 23.26M 2026-06
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
Eisai JPY 883.01B 121.38B 2026-06
Emergent BioSolutions USD 679.5M 41.3M 2023-12
GlaxoSmithKline GBP 17.56B 202M 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Insmed USD 1.63B 20.75M 2026-06
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
Merck USD 36.68B 1.66B 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 615.21M 100.25M 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Veracyte USD 574.78M 52.6M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06